Skip to Content

Medicines, Volume 9, Issue 4

2022 April - 6 articles

Cover Story: Artificial dural substitute (DuraGen®) is frequently used for a variety of conditions and procedures, including traumatic brain injury and stroke. DuraGen® can also be used for duraplasty after tumor removal. Theoretically, DuraGen®-derived neodura is completely replaced by a mature dura after 1 year. In this case, DuraGen® was placed to achieve duraplasty after the removal of tentorial atypical meningioma. Simpson grade I resection was achieved for the recurrent lesion. Collagen fibers running regularly and transversely were observed in the DuraGen®-derived dura mater. Meningioma cell invasion was partially observed in the DuraGen®-derived dura mater. This is the first case report demonstrating invasion of atypical meningioma into the DuraGen®-derived dura mater. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Case Report
  • Open Access
4 Citations
4,616 Views
6 Pages

Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report

  • Ryota Tamura,
  • Yuki Kuranari,
  • Hideki Orikasa and
  • Makoto Katayama

Background: Dura mater infiltration is the main growth pattern of meningiomas. Local recurrence may occur in any type of meningioma, but it is more likely so in atypical meningiomas. Therefore, a wide resection of tumor cell-invaded dura mater is nec...

  • Article
  • Open Access
3 Citations
3,675 Views
12 Pages

The hypertensive pregnant woman is at a higher risk of complications either before, during or after birth and the baby can be adversely affected leading to preterm birth, low birth weight, placental separation (abruption) and other complications. The...

  • Article
  • Open Access
10 Citations
3,745 Views
17 Pages

JUUL™ing and Heating Lead to a Worsening of Arterial Stiffness

  • Julia Benthien,
  • Moritz Meusel,
  • Silja Cayo Talavera,
  • Ingo Eitel,
  • Daniel Drömann and
  • Klaas F. Franzen

Background: The widespread use of the JUUL™ device ignited a discussion about the effects these products have on harm reduction. Therefore, we conducted a study directly comparing the JUUL™ device with a cigarette, a heated tobacco produc...

  • Case Report
  • Open Access
2 Citations
2,959 Views
5 Pages

Background: Acinetobacter spp. are a potential life-threatening cause of severe meningitis noted as a nosocomial infection after neurosurgical procedures in patients admitted to neurosurgical ICUs. Community-acquired Acinetobacter meningitis is...

  • Article
  • Open Access
2 Citations
3,449 Views
12 Pages

Efficacy and Adverse Events of Carboplatin Desensitisation Therapy for Gynaecological Cancer: A Retrospective Study

  • Akihito Yamamoto,
  • Seiryu Kamoi,
  • Shigeru Matsuda,
  • Rieko Kawase,
  • Kazuho Nakanishi and
  • Shunji Suzuki

Background: Carboplatin, the key drug used in treating gynaecological cancer, has an approximately 12–16% risk of hypersensitivity reactions. We aimed to investigate the efficacy and adverse effects of carboplatin desensitisation therapy for gy...

  • Case Report
  • Open Access
3,123 Views
7 Pages

Novel PKD2 Missense Mutation p.Ile424Ser in an Individual with Multiple Hepatic Cysts: A Case Report

  • Seiko Miura,
  • Yo Niida,
  • Chieko Hashizume,
  • Ai Fujii,
  • Yuta Takagaki,
  • Kahoru Kusama,
  • Sumiyo Akazawa,
  • Tetsuya Minami,
  • Tsuyoshi Mukai and
  • Tohru Ito
  • + 5 authors

We report a novel missense mutation, p.Ile424Ser, in the PKD2 gene of an autosomal dominant polycystic kidney disease (ADPKD) patient with multiple liver cysts. A 57-year-old woman presented to our university hospital with abdominal fullness, decreas...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Medicines - ISSN 2305-6320